Publication:
Peripheral blood lymphocyte subgroups in patients undergoing hemodialysis with medium cutoff membranes and high-flux membranes: THE SHE continuation study

dc.contributor.coauthorSevinc, Mustafa
dc.contributor.coauthorYilmaz, Vuslat
dc.contributor.coauthorYilmaz, Abdullah
dc.contributor.coauthorKorkmaz, Hande Yuceer
dc.contributor.coauthorBasturk, Taner
dc.contributor.coauthorAhbap, Elbis
dc.contributor.coauthorSakaci, Tamer
dc.contributor.coauthorLindholm, Bengt
dc.contributor.coauthorUnsal, Abdulkadir
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorHasbal, Nuri Barış
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2025-03-06T20:57:40Z
dc.date.issued2024
dc.description.abstractIntroduction: Chronic kidney disease (CKD) poses a significant global health burden, with increasing prevalence and high morbidity and mortality rates, particularly in end-stage kidney disease (ESKD). While traditional risk factors contribute, the exact mechanisms remain elusive, with inflammation playing a pivotal role. Medium cutoff (MCO) membranes offer promise in improving dialysis outcomes by efficiently clearing uremic toxins without substantial albumin loss. We aimed to elucidate the impact of MCO and high-flux (HF) membranes on peripheral blood lymphocyte subpopulations in hemodialysis patients. Methods: Twenty-four ESKD patients underwent 36 sessions each with MCO and HF membranes. Immunophenotyping by flow cytometry was performed to analyze lymphocyte subsets. Results: NK cell percentages significantly increased with MCO, returning to baseline with HF. Th1 cells decreased post-HF, while Th2 and Tfh cells increased with MCO and persisted. Treg cells remained stable with MCO but decreased with HF. Conclusion: MCO dialysis induced an anti-inflammatory shift, evidenced by increased Th2 and Tfh cells and stable Treg cells. NK cells also responded favorably to MCO. These findings underscore MCO membranes' potential to modulate immune responses and improve patient outcomes in ESKD.
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.identifier.doi10.1159/000541200
dc.identifier.eissn1421-9735
dc.identifier.issn0253-5068
dc.identifier.quartileQ2
dc.identifier.scopus2-s2.0-85206539951
dc.identifier.urihttps://doi.org/10.1159/000541200
dc.identifier.urihttps://hdl.handle.net/20.500.14288/27272
dc.identifier.volume53
dc.identifier.wos1324932300001
dc.keywordsChronic kidney disease
dc.keywordsHemodialysis
dc.keywordsImmunophenotyping
dc.keywordsMedium cutoff membranes
dc.keywordsInflammation
dc.language.isoeng
dc.publisherKARGER
dc.relation.ispartofBLOOD PURIFICATION
dc.subjectHematology
dc.subjectUrology and nephrology
dc.titlePeripheral blood lymphocyte subgroups in patients undergoing hemodialysis with medium cutoff membranes and high-flux membranes: THE SHE continuation study
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.kuauthorHasbal, Nuri Barış
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files